Pharmabiz

Owlet secures CDSCO approval for Dream Sock and plans to launch in India in early 2026

Owlet secures CDSCO approval for Dream Sock and plans to launch in India in early 2026: Lehi, Utah Friday, October 17, 2025, ...
Pharmabiz

Chemist Lutz Ackermann receives Bayer Foundation’s Hansen Family Award

Chemist Lutz Ackermann receives Bayer Foundation’s Hansen Family Award: Leverkusen Friday, October 17, 2025, 13:00 Hrs [IST] ...
Pharmabiz

Curium Group, PeptiDream & PDRadiopharma begin patient enrollment in registrational clinical trial of 64Cu-PSMA-I&T for prostate cancer in Japan

Curium Group, PeptiDream & PDRadiopharma begin patient enrollment in registrational clinical trial of 64Cu-PSMA-I&T for prostate cancer in Japan: Paris, France Friday, October 17, ...
Pharmabiz

Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights: San Diego Friday, October 17, 2025, 17:00 Hrs [IST] Illu ...
Pharmabiz

AI tools that could detect diseases earlier selected for next phase of MHRA’s ‘AI Airlock’ programme

AI tools that could detect diseases earlier selected for next phase of MHRA’s ‘AI Airlock’ programme: United Kingdom Friday, October 17, 2025, 16:00 Hrs [IST] Artificial int ...
Pharmabiz

Biorad Medisys accelerates vascular and stroke care through new partnerships and technology

Biorad Medisys accelerates vascular and stroke care through new partnerships and technology: Our Bureau, Mumbai Friday, October 17, 2025, 16:15 Hrs [IST] Biorad Medisys Pvt. Ltd.
Pharmabiz

Marengo Asia Hospitals acquires majority stake in 350-bed Sunshine Global Hospitals

Marengo Asia Hospitals acquires majority stake in 350-bed Sunshine Global Hospitals: Our Bureau, Mumbai Friday, October 17, 2025, 10:45 Hrs [IST] Marengo Asia Hospitals, a multi-s ...
Pharmabiz

SK bioscience files for first-in-human trial of universal coronavirus vaccine, GBP511 phase 1/2 study in Australia

SK bioscience files for first-in-human trial of universal coronavirus vaccine, GBP511 phase 1/2 study in Australia: Republic of Korea Friday, October 17, 2025, 15:00 Hrs [IST] SK ...
Pharmabiz

Novartis Fabhalta meets phase III primary endpoint, slows kidney function decline in patients with IgA nephropathy

Novartis Fabhalta meets phase III primary endpoint, slows kidney function decline in patients with IgA nephropathy: Basel Friday, October 17, 2025, 10:00 Hrs [IST] Novartis announ ...
Pharmabiz

Suraksha Clinic and Diagnostics conducts East Zone AMBI workshop on capillary electrophoresis and immunotyping

Suraksha Clinic and Diagnostics conducts East Zone AMBI workshop on capillary electrophoresis and immunotyping: Our Bureau, Mumbai Friday, October 17, 2025, 13:45 Hrs [IST] Suraks ...
Pharmabiz

Roche presents major advances for its sequencing by expansion technology, including a new Guinness World Record, at the ASHG conference 2025

Roche presents major advances for its sequencing by expansion technology, including a new Guinness World Record, at the ASHG conference 2025: Basel Friday, October 17, 2025, 12:00 ...
Pharmabiz

Boehringer Ingelheim advances cancer antibody-drug conjugate portfolio with asset from AimedBio

Boehringer Ingelheim advances cancer antibody-drug conjugate portfolio with asset from AimedBio: Ingelheim, Germany Friday, October 17, 2025, 11:00 Hrs [IST] Boehringer Ingelheim ...